Skip to main content

Advertisement

SpringerLink
Log in

Targeting tumor cell destruction with CD64-directed bispecific fusion proteins

  • ORIGINAL ARTICLE
  • Published:
Cancer Immunology, Immunotherapy Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Author information

Authors and Affiliations

  1. Medarex Inc., 1545 Route 22 East, Annandale, NJ 08801, USA E-mail: rgrazian@injersey.com, , , , , , US

    Robert F. Graziano, Joel Goldstein, Karuna Sundarapandiyan, Chezian Somasundaram, Tibor Keler & Yashwant M. Deo

Authors
  1. Robert F. Graziano
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Joel Goldstein
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Karuna Sundarapandiyan
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Chezian Somasundaram
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Tibor Keler
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Yashwant M. Deo
    View author publications

    You can also search for this author in PubMed Google Scholar

Additional information

Accepted: 14 October 1997

Rights and permissions

Reprints and permissions

About this article

Cite this article

Graziano, R., Goldstein, J., Sundarapandiyan, K. et al. Targeting tumor cell destruction with CD64-directed bispecific fusion proteins. Cancer Immunol Immunother 45, 124–127 (1997). https://doi.org/10.1007/s002620050413

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s002620050413

Keywords

Search

Navigation